Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73,602 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and validation of a nomogram for assessing survival in extensive-stage small-cell lung cancer patients with superior vena cava syndrome referred for thoracic radiotherapy: a comparison of upfront vs. consolidative approaches.
Mei T, Xiu W, Yang X, Tian X, Yu Y, Xu Y, Zhou L, Zhou X, Liu Y, Zou B, Xue J, Ao R, Lu Y, Gong Y. Mei T, et al. Among authors: xu y. Strahlenther Onkol. 2021 Dec;197(12):1072-1083. doi: 10.1007/s00066-021-01783-4. Epub 2021 Apr 28. Strahlenther Onkol. 2021. PMID: 33909099
Predicting severe acute radiation pneumonitis in patients with non-small cell lung cancer receiving postoperative radiotherapy: Development and internal validation of a nomogram based on the clinical and dose-volume histogram parameters.
Tang X, Li Y, Tian X, Zhou X, Wang Y, Huang M, Ren L, Zhou L, Xue J, Ding Z, Zhu J, Xu Y, Peng F, Wang J, Lu Y, Gong Y. Tang X, et al. Among authors: xu y. Radiother Oncol. 2019 Mar;132:197-203. doi: 10.1016/j.radonc.2018.10.016. Epub 2018 Oct 29. Radiother Oncol. 2019. PMID: 30385172
Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.
Zhou Y, Yan T, Zhou X, Cao P, Luo C, Zhou L, Xu Y, Liu Y, Xue J, Wang J, Wang Y, Lu Y, Liang B, Gong Y. Zhou Y, et al. Among authors: xu y. Strahlenther Onkol. 2020 Jun;196(6):505-514. doi: 10.1007/s00066-019-01552-4. Epub 2019 Dec 11. Strahlenther Onkol. 2020. PMID: 31828393
Secondary Infections After Diagnosis of Severe Radiation Pneumonitis (SRP) Among Patients With Non-Small Cell Lung Cancer: Pathogen Distributions, Choice of Empirical Antibiotics, and the Value of Empirical Antifungal Treatment.
Mei T, Yang X, Yu Y, Tian X, Deng Q, Xu Y, Zhou L, Zhou X, Liu Y, Zou B, Xue J, Quan M, Yan L, Lu Y, Gong Y. Mei T, et al. Among authors: xu y. Int J Radiat Oncol Biol Phys. 2022 Jan 1;112(1):179-187. doi: 10.1016/j.ijrobp.2021.08.022. Epub 2021 Aug 19. Int J Radiat Oncol Biol Phys. 2022. PMID: 34418467
Stereotactic body radiotherapy to the primary lung lesion improves the survival of the selected patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: a real-world study.
Wei H, Zhou X, Yang H, Gong Y, Wang J, Xu Y, Zhou L, Xue J, Zou B, Zhang Y, Zhu J, Peng F, Huang M, Lu Y, Liu Y. Wei H, et al. Among authors: xu y. J Cancer Res Clin Oncol. 2022 Oct;148(10):2589-2598. doi: 10.1007/s00432-021-03831-z. Epub 2021 Oct 20. J Cancer Res Clin Oncol. 2022. PMID: 34669037
73,602 results
You have reached the last available page of results. Please see the User Guide for more information.